Topical photodynamic therapy in dermatology

Journal of Photochemistry and Photobiology B: Biology

Volumn 36, Issue 2, 1996, Pages 213-219

  Szeimies, Rolf Markus ^a   Calzavara Pinton, PierGiacomo ^b   Karrer, Sigrid ^a   Ortel, Bernhard ^c   Landthaler, Michael ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF BRESCIA   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Aminolevulinic acid; Hematoporphyrin derivative; Inflammatory skin diseases; Photodynamic therapy; Skin cancer; Tetrasodium mesotetraphenyl porphinesulfonate

Indexed keywords

AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; HEMATOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT; PRODRUG; PROTOPORPHYRIN; TETRAPHENYLPORPHINESULFONIC ACID;

ACTINIC KERATOSIS; CANCER THERAPY; CONFERENCE PAPER; DERMATOLOGY; DRUG CLEARANCE; DRUG MECHANISM; DRUG METABOLISM; DRUG PENETRATION; HUMAN; LASER; MYCOSIS FUNGOIDES; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PSORIASIS; SKIN CANCER; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET RADIATION;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 0030294563     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(96)07375-7     Document Type: Conference Paper

References (43)

1. [1] H. von Tappeiner, A. Jodlbauer, Die sensibilisierende Wirkung fluorescierender Substanzen. Gesammelte Untersuchungen über die photodynamische Erscheinung, FCW Vogel, Leipzig, 1907.
2. [2] H. von Tappeiner, A. Jesionek, Therapeutische Versuche mit fluorescierenden Stoffen, Münch Med Wochenschr, 47 (1903) 2042-2044.
3. [3] F. Meyer-Betz, Untersuchungen über die biologische (photodynamische) Wirkung des Hämatopophyrins und anderer Derivative des Blut-und Gallenfarbstoffs, Dtsch. Arch. Klin. Med., 112 (1913) 476-503.
4. [4] R.S. Wooten, K.C. Smith, D.A. Ahlquist, S.A. Muller, R.K. Balm, Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative, Lasers Surg. Med., 8 (1988) 294-300.
5. [5] J.C. Kennedy, R.H. Pettier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol., B: Biol., 14 (1992) 275-292.
6. [6] A. Kappas, S. Sassa, R.A. Galbraith, Y. Nordmann, The porphyrias, in C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (eds.), The metabolic basis of inherited disease, McGraw-Hill, New York, 6th edn., 1989, pp 1305-1366.
7. [7] S. Iinuma, S.S. Farshi, B. Ortel, T. Hasan, A mechanistic study of cellular photodestruction with 5-aminolevulinic acid-induced porphyrin, Br. J. Cancer, 79 (1994) 21-28.
8. [8] D.X.C. Divaris, J.C. Kennedy, R.H. Pottier, Phototoxic damage to sebaceous glands and hair follicles of mice following systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence, Am. J. Pathol., 136 (1990) 891-897.
9. [9] J. Bedwell, A.J. McRobert, D. Phillips, S.C. Bown, Fluorescence distribution and photodynamic effect of ALA-induced PpIX in the DMH rat colonic tumour model, Br. J. Cancer, 65 (1992) 818-824.
10. [10] N. Rebeiz, C.C. Rebeiz, S. Arkins, K.W. Kelley, C.A. Rebeiz, Photodestruction of tumor cells by induction of endogenous accumulation of protoporphyrin IX: enhancement by 1,10-phenanthroline, Photochem. Photobiol., 55 (1992) 431-435.
11. [11] R.-M. Szeimies, T. Sassy, M. Landthaler, Penetration potency of topical applied δ-aminolevulinic acid for photodynamic therapy of basal cell carcinoma, Photochem. Photobiol., 59 (1994) 73-76.
12. [12] R.-M. Szeimies, S. Karrer, A. Sauerwald, M. Landthaler, Topical photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study, Dermatology, 192 (1996) 246-251.
13. [13] C. Abels, P. Heil, M. Dellian, G.E.H. Kuhnle, R. Baumgartner, A.E. Goetz, In vivo kinetics and spectra of 5-aminolevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster, Br. J. Cancer, 70 (1994) 826-833.
14. [14] J.M. Wessels, H.K. Seidlitz, R. Sroka, E. Unsöld, The photodegradation of protoporphyrin in cells: A time-resolved study, in P. Spinelli, M. Dal Fante, R. Marchesini (eds.), Photodynamic Therapy and Biomedical Lasers, Elsevier Science B.V., 1992, pp. 684-687.
15. [15] J.C. Kennedy, R.H. Pottier, D.C. Pross, Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience, J. Photochem. Photobiol., B: Biol., 6 (1990) 143-148.
16. [16] B. Thiele, P. Grotmann, G. Hüttmann, H. Diddens, H. Hörauf, Topische photodynamische Therapie (TPDT) von Basaliomen: Klinische, histologische und experimentelle Ergebnisse (erste Mitteilung), Z. Hautkr., 3 (1994) 161-164.
17. [17] T. Warloe, Q. Peng, J. Moan, H.L. Qvist, K.E, Giercksky, Photochemotherapy of multiple basal cell carcinoma with endogenous porphyrins induced by topical application of 5-aminolevulinic acid, in P. Spinelli, M. Dal Fante, R. Marchesini (eds.), Photodynamic therapy and biomedical lasers, Elsevier Science B.V., (1992), pp. 449-453.
18. [18] A.F. Hürlimann, R.G. Panizzon, A. Burg, Topical photodynamic treatment of skin tumors and dermatoses, Dermatology, 3 (1994) 327 (Abstract).
19. [19] P. Wolf, E. Rieger, H. Kerl, Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid, J. Am. Acad. Dermatol., 28 (1993) 17-21.
20. [20] F. Cairnduff, M R. Stringer, E.J. Hudson, D.V. Ash, S.B. Brown, Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer, Br. J. Cancer, 69 (1994) 605-608.
21. [21] K. Svanberg, T. Andersson, D. Killander, I. Wang, U. Stenram, S. Andersson-Engels, R. Berg, J. Johansson, S. Svanberg, Photodynamic therapy of non-melanoma malignant tumours of the skin using topical 6-amino levulinic acid sensitization and laser irradiation, Br. J. Dermatol., 130 (1994) 743-751.
22. [22] P.G. Calzavara-Pinton, Repetitive Photodynamic therapy with topical o-aminolevulinic acid as an appropriate approach to routine treatment of superficial non-melanoma skin tumours, J. Photochem. Photobiol. B: Biol., 29 (1995) 53-57.
23. [23] H. Hoerauf, G. Hüttmann, H. Diddens, B. Thiele, H. Laqua, Die Photodynamische Therapie (PDT) des Lidbasalioms nach topischer Applikation von δ-Aminolävulinsäure (ALA), Ophthalmologe, 91 (1994) 824-829.
24. [24] P. Wolf, R. Fink-Puches, L. Cerroni, H. Kerl, Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid, J. Am. Acad. Dermatol., 31 (1994) 678-680.
25. [25] W.H. Boehncke, W. Sterry, R. Kaufmann, Treatment of psoriasis by topical photodynamic therapy with polychromatic light, Lancet, 343 (1994) 801 (Letter).
26. [26] G.D. Weinstein, J.L. McCullough, E.W. Jeffes, J.S. Nelson, N.L. Fong, A.J. McCormick, Photodynamic therapy (PDT) of psoriasis with topical delta aminolevulinic acid (ALA): A pilot dose ranging study, Photodermatol. Photoimmunol. Photomed., 10 (1994) 92 (Abstract).
27. [27] A.L. Abramson, A. Alvi, V.M. Mullooly, Clinical exacerbation of systemic lupus erythematosus after photodynamic therapy of laryngotracheal papillomatosis, Lasers Surg. Med., 13 (1993) 677-679.
28. [28] P.G. Calzavara-Pinton, F. Facchetti, S. Battocchio, C. Zane, G. De Panfilis, Clinical, morphological and immunohistochemical analyses of psoriatic lesions treated with ALA and UVA light, Photochem. Photobiol., 59 (1994) 26S (Abstract).
29. [29] J.L. McCullough, G.D. Weinstein, L.L. Lemus, W Rampone, J.J. Jenkins, Development of a topical hematoporphyrin derivative formulation: Characterization of photosensitizing effects in vivo, J. Invest. Dermatol., 81 (1983) 528-532.
30. [30] G. Monfrecola, F. Dánna, M. Delfino, Topical hematoporphyrin plus UVA for treatment of alopecia areata, Photodermatol. Photoimmunol. Photomed., 4 (1987) 305-306.
31. [31] V. Sacchini, E. Melloni, R. Marchesini, T. Fabrizio, N. Cascinelli, O. Santoro, F. Zunino, S. Andreola, G. Bandieramonte, Topical administration of tetrasodium-meso-tetraphenyl-porphinesulfonate (TPPS) and red light irradiation for the treatment of superficial neoplastic lesions, Tumori, 73 (1987) 19-23.
32. [32] R.-M. Szeimies, F. Eckert, S. Tunger, W. Bäumler, M. Landthaler, Wavelength-dependent photodynamic inactivation of HaCaT human keratinocytes after preincubation with delta-aminolevulinic acid, Arch. Dermatol. Res., 286 (1994) 152-153 (Abstract).
33. [33] C. Fritsch, P. Lehmann, K. Bolsen, T. Ruzicka, G. Goerz, Photodynamische Diagnostik und Photodynamische Therapie von aktinischen Keratosen, Z. Hautkr., 69 (1994) 713-715.
34. [34] R.-M. Szeimies, S. Karrer, A. Heine, U. Hohenleutner, M. Landthater, Topical photodynamic therapy with 5-aminolevulinic acid in the treatment of arsenic-induced skin tumors, Eur. J. Dermatol., 5 (1995) 208-211.
35. [35] R.-M. Szeimies, R. Hein, W. Bäumler, A. Heine, M. Landthaler, A possible new incoherent lamp for photodynamic treatment of superficial skin lesions, Acta. Derm. Venereol. (Stockh), 74 (1994) 117-119.
36. [36] P. Charlesworth, T.G. Truscott, The use of 5-aminolevulinic acid (ALA) in photodynamic therapy, J. Photochem. Photobiol. B: Biol., 18 (1993) 99-100.
37. [37] K. König, H. Schneckenburger, A. Rück, R. Steiner, In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins, J. Photochem. Photobiol. B: Biol., 18 (1993) 287-290.
38. [38] B. Ortel, A. Tanew, H. Hönigsmann, Lethal photosensitization by endogenous porphyrins of PAM cells - modification by desferrioxamine, J. Photochem. Photobiol. B: Biol., 17 (1993) 273-278.
39. [39] J. Hanania, Z. Malik, The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells, Cancer Lett, 65 (1992) 127-131.
40. [40] Q. Peng, T. Warloe, J. Moan, Topically-applied ALA-based PDT for nodulo-ulcerative basal cell carcinoma, IPA news, 7 (1995) 2.
41. [41] P. Wyss, Y. Tadir, B.J. Tromberg, L. Liaw, T. Krasieva, M.W. Berns, Benzoporphyrin derivative: a potent photosensitizer for photodynamic destruction of rabbit endometrium, Obstet Gynecol, 84 (1994) 409-414.
42. [42] C. Richert, J.M. Wessels, M. Müller, M. Kisters, T. Benninghaus, A.E. Goetz, Photodynamic antitumor agents: beta-methoxyethyl groups give access to functionalized porphycenes and enhance cellular uptake and activity, J. Med. Chem., 37 (1994) 2797-2807.
43. [43] G. Jori, Personal communication, 1994.